Atlas Trials

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Clinical trial NCT01637558 · COMPLETED

Trial details

NCT number
NCT01637558
Sponsor
University of Cape Town
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
TuberculosisHIV
Start date
2012-11-01
Primary completion
2017-07-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.